Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.
Mónica InêsTeresa CoelhoIsabel ConceiçãoLara FerreiraMamede de CarvalhoJoão CostaPublished in: Orphanet journal of rare diseases (2020)
Hereditary Transthyretin Amyloidosis Polyneuropathy symptoms and progressive associated disabilities substantially decrease patient's health-related quality of life. Clinical strategies focused on health-related quality of life preservation such as close follow-up of asymptomatic carriers, prompt diagnosis and adequate, early treatment would benefit patient's long-term outcomes, slowing the progressive decline in health-related quality of life.